$DYAX Recent News Friday’s biggest gaining a
Post# of 74552
Posted On: 01/18/2015 11:31:11 AM
$DYAX Recent News
Friday’s biggest gaining and declining stocks 1:33 p.m. June 15, 2012 - MarketWatch
Dyax shares fall 13% in preopen trade 8:07 a.m. June 15, 2012 - Greg Morcroft
Wednesday's biggest gaining and declining stocks 5:03 p.m. Dec. 2, 2009 - MarketWatch
Dyax, Santarus, CytRx soar; Hemispherx craters 11:38 a.m. Dec. 2, 2009 - Val Brickates Kennedy
Dyax leads drug stocks north 9:46 a.m. Dec. 2, 2009 - Val Brickates Kennedy
Drug stocks slide; Lundbeck slides on drug woes 2:35 p.m. June 8, 2009 - Val Brickates Kennedy
Accenture shares drop following forecast cut; Dyax falls 4:31 p.m. March 26, 2009 - Carla Mozee
Monday's biggest gaining and declining stocks 3:49 p.m. Aug. 18, 2008 - MarketWatch
Drug stocks slip, as Amylin falls on drug warning 12:45 p.m. Aug. 18, 2008 - Val Brickates Kennedy
Dyax to apply for FDA approval of DX-88 in fourth quarter 8:13 a.m. Aug. 18, 2008 - Val Brickates Kennedy
Dyax slides as potential rival files for FDA approval 4:04 p.m. March 6, 2008 - Val Brickates Kennedy
Shares in Europe rally on Buffett bond proposal 2:12 p.m. Feb. 12, 2008 - Sarah Turner
Drug stocks edge higher; Schering-Plough gains 10:40 a.m. Feb. 12, 2008 - Val Brickates Kennedy
Friday's biggest stock gainers and decliners 3:35 p.m. July 13, 2007 - Gabriel Madway
Dyax prices public offering of 10.5M shares at $3.67 a share 6:06 a.m. July 13, 2007 - Aude Lagorce
Dyax prices public offering at $3.67 a share 6:02 a.m. July 13, 2007 - Aude Lagorce
Monday's biggest stock gainers and decliners 4:06 p.m. July 9, 2007 - Gabriel Madway
Dyan files to sell 9.5 million shares 5:27 a.m. July 9, 2007 - Steve Goldstein
Dyax files to sell 9.5 million shares 5:26 a.m. July 9, 2007 - Steve Goldstein
More biotech partnerships expected 2:40 p.m. June 25, 2007 - Carolyn Pritchard
Commit To Purchase Dyax Corp At $12.50, Earn 24.9% Annualized Using Options 12:08 p.m. Dec. 24, 2014 - TheStreet.com
Can The Uptrend Continue for Dyax (DYAX)? - Tale of the Tape 8:22 a.m. Dec. 23, 2014 - Zacks.com
How Dyax Corp. (DYAX) Stock Stands Out in a Strong Industry - Tale of the Tape 8:54 a.m. Dec. 18, 2014 - Zacks.com
Can Dyax (DYAX) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape 9:04 a.m. Dec. 10, 2014 - Zacks.com
Why Dyax (DYAX) Could Be an Impressive Growth Stock - Tale of the Tape 8:47 a.m. Dec. 5, 2014 - Zacks.com
Today's Weak On High Volume Stock: Dyax (DYAX) 10:00 a.m. Dec. 1, 2014 - TheStreet.com
Amgen Ends Gastric Cancer Drug Studies on Safety Review - Analyst Blog 1:20 p.m. Nov. 25, 2014 - Zacks.com
Why Intercept Pharmaceuticals (ICPT) Could Be Positioned for a Slump - Tale of the Tape 8:40 a.m. Nov. 25, 2014 - Zacks.com
Strong On High Relative Volume: Dyax (DYAX) 10:00 a.m. Nov. 24, 2014 - TheStreet.com
Why Dyax (DYAX) Could Be Positioned for a Surge? - Tale of the Tape 8:42 a.m. Nov. 7, 2014 - Zacks.com
Can Dyax (DYAX) Stock Continue to Grow Earnings? - Tale of the Tape 8:49 a.m. Nov. 4, 2014 - Zacks.com
10-Q: DYAX CORP 4:32 p.m. Nov. 3, 2014 - Edgar Online - (EDG = 10Q, 10K)
BIND Therapeutics, Inc. (BIND) Surges: Stock Rises 14.2% Higher - Tale of the Tape 8:11 a.m. Oct. 31, 2014 - Zacks.com
Update: Biotech Dyax Exceeds Q3 Estimates With The Future Looking Bright 11:15 a.m. Oct. 30, 2014 - Seeking Alpha
Will Dyax (DYAX) Continue to Surge Higher? - Tale of the Tape 8:04 a.m. Oct. 30, 2014 - Zacks.com
Top Health Care and Biotech Stocks to Buy That Have Already Posted Earnings 7:22 a.m. Oct. 30, 2014 - 247WallSt.com
Dyax's (DYAX) CEO Gustav Christiansen on Q3 2014 Results - Earnings Call Transcript 7:54 p.m. Oct. 28, 2014 - Seeking Alpha
Dyax (DYAX) Q3 2014 Results - Earnings Call Webcast 3:55 p.m. Oct. 28, 2014 - Seeking Alpha
Notable earnings after Tuesday's close 4:35 p.m. Oct. 27, 2014 - Seeking Alpha
10-Q: DYAX CORP 4:29 p.m. Aug. 1, 2014 - Edgar Online - (EDG = 10Q, 10K)
LeeAnn Ali Joins BioBridges as Executive Director, Clinical Operations 8:04 a.m. Jan. 13, 2015 - Marketwired
Technical Coverage on Biotech Stocks - Arena Pharma, XOMA, Dyax, Mast Therapeutics, and Tekmira Pharma 8:50 a.m. Jan. 2, 2015 - PR Newswire - PRF
Dyax Corp.’s First-in-Human Trial for DX-2930 Conducted by Vince and Associates Clinical Research Featured in the Annals of Allergy, Asthma & Immunology 8:01 a.m. Dec. 18, 2014 - BusinessWire - BZX
Dyax Corp. to Participate in the 25th Annual Oppenheimer Healthcare Conference 7:01 a.m. Dec. 3, 2014 - BusinessWire - BZX
Technical Snapshot on Biotech Stocks - Keryx Biopharma, Dyax, Mast Therapeutics, Cubist Pharma, and Intrexon 8:30 a.m. Dec. 1, 2014 - PR Newswire - PRF
Dyax Corp. Recognized as a “Top Place to Work” by The Boston Globe 7:30 a.m. Nov. 18, 2014 - BusinessWire - BZX
Dyax Corp. Announces Expansion of Phase 1b Clinical Trial for DX-2930 7:31 a.m. Nov. 3, 2014 - BusinessWire - BZX
Dyax Corp. Announces Third Quarter 2014 Financial Results 3:03 p.m. Oct. 28, 2014 - BusinessWire - BZX
Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 7:35 a.m. Oct. 27, 2014 - PR Newswire - PRF
Dyax Corp. to Host Third Quarter 2014 Earnings Call and Webcast 7:01 a.m. Oct. 14, 2014 - BusinessWire - BZX
Dyax Corp. to Participate in the Leerink Partners Rare Disease Roundtable 6:00 a.m. Sept. 25, 2014 - BusinessWire - BZX
Dyax Corp. Highlights Recent Progress in Licensing and Funded Research Portfolio 6:12 a.m. Sept. 22, 2014 - BusinessWire - BZX
Dyax Corp. Announces Issuance of Two Key U.S. Patents for DX-2930 6:01 a.m. Sept. 15, 2014 - BusinessWire - BZX
Biotech Equities Technical Analysis -- BioMarin Pharma, Merrimack Pharma, Sangamo BioSciences, ZIOPHARM Oncology, and Dyax 7:50 a.m. Aug. 7, 2014 - PR Newswire - PRF
Scheduled Conference Calls and Product Launches - Research Reports on Anika Therapeutics, NeoGenomics, HeartWare, Sangamo and Dyax 7:40 a.m. July 23, 2014 - PR Newswire - PRF
Dyax Corp. Announces Publication of Scientific Data for DX-2930 in Peer-Reviewed Journals 7:01 a.m. July 23, 2014 - BusinessWire - BZX
Financial Guidance, Appointments, Board Elections, and Technical Updates - Analyst Notes on Amedisys, Dyax, TearLab, Celladon and Alphatec 5:00 a.m. July 2, 2014 - PR Newswire - PRF
Pre-Market Review on Health Care Sector Equities -- Research on Dyax, Repligen, Vanda Pharma, and Ironwood Pharma 6:50 a.m. July 1, 2014 - PR Newswire - PRF
Dyax Corp. to Participate in the 2014 Wells Fargo Healthcare Conference 7:01 a.m. June 10, 2014 - BusinessWire - BZX
Dyax Corp. to Participate in the Jefferies Global Healthcare Conference 7:01 a.m. May 29, 2014 - BusinessWire - BZX
Friday’s biggest gaining and declining stocks 1:33 p.m. June 15, 2012 - MarketWatch
Dyax shares fall 13% in preopen trade 8:07 a.m. June 15, 2012 - Greg Morcroft
Wednesday's biggest gaining and declining stocks 5:03 p.m. Dec. 2, 2009 - MarketWatch
Dyax, Santarus, CytRx soar; Hemispherx craters 11:38 a.m. Dec. 2, 2009 - Val Brickates Kennedy
Dyax leads drug stocks north 9:46 a.m. Dec. 2, 2009 - Val Brickates Kennedy
Drug stocks slide; Lundbeck slides on drug woes 2:35 p.m. June 8, 2009 - Val Brickates Kennedy
Accenture shares drop following forecast cut; Dyax falls 4:31 p.m. March 26, 2009 - Carla Mozee
Monday's biggest gaining and declining stocks 3:49 p.m. Aug. 18, 2008 - MarketWatch
Drug stocks slip, as Amylin falls on drug warning 12:45 p.m. Aug. 18, 2008 - Val Brickates Kennedy
Dyax to apply for FDA approval of DX-88 in fourth quarter 8:13 a.m. Aug. 18, 2008 - Val Brickates Kennedy
Dyax slides as potential rival files for FDA approval 4:04 p.m. March 6, 2008 - Val Brickates Kennedy
Shares in Europe rally on Buffett bond proposal 2:12 p.m. Feb. 12, 2008 - Sarah Turner
Drug stocks edge higher; Schering-Plough gains 10:40 a.m. Feb. 12, 2008 - Val Brickates Kennedy
Friday's biggest stock gainers and decliners 3:35 p.m. July 13, 2007 - Gabriel Madway
Dyax prices public offering of 10.5M shares at $3.67 a share 6:06 a.m. July 13, 2007 - Aude Lagorce
Dyax prices public offering at $3.67 a share 6:02 a.m. July 13, 2007 - Aude Lagorce
Monday's biggest stock gainers and decliners 4:06 p.m. July 9, 2007 - Gabriel Madway
Dyan files to sell 9.5 million shares 5:27 a.m. July 9, 2007 - Steve Goldstein
Dyax files to sell 9.5 million shares 5:26 a.m. July 9, 2007 - Steve Goldstein
More biotech partnerships expected 2:40 p.m. June 25, 2007 - Carolyn Pritchard
Commit To Purchase Dyax Corp At $12.50, Earn 24.9% Annualized Using Options 12:08 p.m. Dec. 24, 2014 - TheStreet.com
Can The Uptrend Continue for Dyax (DYAX)? - Tale of the Tape 8:22 a.m. Dec. 23, 2014 - Zacks.com
How Dyax Corp. (DYAX) Stock Stands Out in a Strong Industry - Tale of the Tape 8:54 a.m. Dec. 18, 2014 - Zacks.com
Can Dyax (DYAX) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape 9:04 a.m. Dec. 10, 2014 - Zacks.com
Why Dyax (DYAX) Could Be an Impressive Growth Stock - Tale of the Tape 8:47 a.m. Dec. 5, 2014 - Zacks.com
Today's Weak On High Volume Stock: Dyax (DYAX) 10:00 a.m. Dec. 1, 2014 - TheStreet.com
Amgen Ends Gastric Cancer Drug Studies on Safety Review - Analyst Blog 1:20 p.m. Nov. 25, 2014 - Zacks.com
Why Intercept Pharmaceuticals (ICPT) Could Be Positioned for a Slump - Tale of the Tape 8:40 a.m. Nov. 25, 2014 - Zacks.com
Strong On High Relative Volume: Dyax (DYAX) 10:00 a.m. Nov. 24, 2014 - TheStreet.com
Why Dyax (DYAX) Could Be Positioned for a Surge? - Tale of the Tape 8:42 a.m. Nov. 7, 2014 - Zacks.com
Can Dyax (DYAX) Stock Continue to Grow Earnings? - Tale of the Tape 8:49 a.m. Nov. 4, 2014 - Zacks.com
10-Q: DYAX CORP 4:32 p.m. Nov. 3, 2014 - Edgar Online - (EDG = 10Q, 10K)
BIND Therapeutics, Inc. (BIND) Surges: Stock Rises 14.2% Higher - Tale of the Tape 8:11 a.m. Oct. 31, 2014 - Zacks.com
Update: Biotech Dyax Exceeds Q3 Estimates With The Future Looking Bright 11:15 a.m. Oct. 30, 2014 - Seeking Alpha
Will Dyax (DYAX) Continue to Surge Higher? - Tale of the Tape 8:04 a.m. Oct. 30, 2014 - Zacks.com
Top Health Care and Biotech Stocks to Buy That Have Already Posted Earnings 7:22 a.m. Oct. 30, 2014 - 247WallSt.com
Dyax's (DYAX) CEO Gustav Christiansen on Q3 2014 Results - Earnings Call Transcript 7:54 p.m. Oct. 28, 2014 - Seeking Alpha
Dyax (DYAX) Q3 2014 Results - Earnings Call Webcast 3:55 p.m. Oct. 28, 2014 - Seeking Alpha
Notable earnings after Tuesday's close 4:35 p.m. Oct. 27, 2014 - Seeking Alpha
10-Q: DYAX CORP 4:29 p.m. Aug. 1, 2014 - Edgar Online - (EDG = 10Q, 10K)
LeeAnn Ali Joins BioBridges as Executive Director, Clinical Operations 8:04 a.m. Jan. 13, 2015 - Marketwired
Technical Coverage on Biotech Stocks - Arena Pharma, XOMA, Dyax, Mast Therapeutics, and Tekmira Pharma 8:50 a.m. Jan. 2, 2015 - PR Newswire - PRF
Dyax Corp.’s First-in-Human Trial for DX-2930 Conducted by Vince and Associates Clinical Research Featured in the Annals of Allergy, Asthma & Immunology 8:01 a.m. Dec. 18, 2014 - BusinessWire - BZX
Dyax Corp. to Participate in the 25th Annual Oppenheimer Healthcare Conference 7:01 a.m. Dec. 3, 2014 - BusinessWire - BZX
Technical Snapshot on Biotech Stocks - Keryx Biopharma, Dyax, Mast Therapeutics, Cubist Pharma, and Intrexon 8:30 a.m. Dec. 1, 2014 - PR Newswire - PRF
Dyax Corp. Recognized as a “Top Place to Work” by The Boston Globe 7:30 a.m. Nov. 18, 2014 - BusinessWire - BZX
Dyax Corp. Announces Expansion of Phase 1b Clinical Trial for DX-2930 7:31 a.m. Nov. 3, 2014 - BusinessWire - BZX
Dyax Corp. Announces Third Quarter 2014 Financial Results 3:03 p.m. Oct. 28, 2014 - BusinessWire - BZX
Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 7:35 a.m. Oct. 27, 2014 - PR Newswire - PRF
Dyax Corp. to Host Third Quarter 2014 Earnings Call and Webcast 7:01 a.m. Oct. 14, 2014 - BusinessWire - BZX
Dyax Corp. to Participate in the Leerink Partners Rare Disease Roundtable 6:00 a.m. Sept. 25, 2014 - BusinessWire - BZX
Dyax Corp. Highlights Recent Progress in Licensing and Funded Research Portfolio 6:12 a.m. Sept. 22, 2014 - BusinessWire - BZX
Dyax Corp. Announces Issuance of Two Key U.S. Patents for DX-2930 6:01 a.m. Sept. 15, 2014 - BusinessWire - BZX
Biotech Equities Technical Analysis -- BioMarin Pharma, Merrimack Pharma, Sangamo BioSciences, ZIOPHARM Oncology, and Dyax 7:50 a.m. Aug. 7, 2014 - PR Newswire - PRF
Scheduled Conference Calls and Product Launches - Research Reports on Anika Therapeutics, NeoGenomics, HeartWare, Sangamo and Dyax 7:40 a.m. July 23, 2014 - PR Newswire - PRF
Dyax Corp. Announces Publication of Scientific Data for DX-2930 in Peer-Reviewed Journals 7:01 a.m. July 23, 2014 - BusinessWire - BZX
Financial Guidance, Appointments, Board Elections, and Technical Updates - Analyst Notes on Amedisys, Dyax, TearLab, Celladon and Alphatec 5:00 a.m. July 2, 2014 - PR Newswire - PRF
Pre-Market Review on Health Care Sector Equities -- Research on Dyax, Repligen, Vanda Pharma, and Ironwood Pharma 6:50 a.m. July 1, 2014 - PR Newswire - PRF
Dyax Corp. to Participate in the 2014 Wells Fargo Healthcare Conference 7:01 a.m. June 10, 2014 - BusinessWire - BZX
Dyax Corp. to Participate in the Jefferies Global Healthcare Conference 7:01 a.m. May 29, 2014 - BusinessWire - BZX
(0)
(0)